Johnson & Johnson Non-GAAP EPS of $2.42 beats by $0.21, revenue of $22.5B beats by $330M

Adjusted Operational Sales

Change vs. Prior Year / Mid-point

5.7% – 6.2% / 6.0%

5.5% – 6.0% / 5.8%

Operational Sales^2,5/ Mid-point

$89.4B – $89.8B / $89.6B

$89.2B – $89.6B / $89.4B

Change vs. Prior Year / Mid-point

6.3% – 6.8% / 6.6%

6.1% – 6.6% / 6.4%

Estimated Reported Sales/ Mid-point

$88.4B – $88.8B / $88.6B

$88.0B – $88.4B / $88.2B

Change vs. Prior Year / Mid-point

5.1% – 5.6% / 5.4%

4.7% – 5.2% / 5.0%

Adjusted Operational EPS (Diluted)/ Mid-point

$9.86 – $9.96 / $9.91

$10.00 – $10.10 / $10.05

Change vs. Prior Year / Mid-point

(0.6)% – 0.4% / (0.1)%

0.8% – 1.8% / 1.3%

Adjusted EPS (Diluted) / Mid-point

$9.88 – $9.98 / $9.93

$9.97 – $10.07 / $10.02

Change vs. Prior Year / Mid-point

(0.4)% – 0.6% / 0.1%

0.5% – 1.5% / 1.0%